Micro-Sphere S.A. is a contract development and manufacturing organisation (CDMO) with specialist expertise in the spray drying of APIs and HPAPIs. Founded in 1998, we have a long track record in ove...
Micro-Sphere S.A. is a contract development and manufacturing organisation (CDMO) with specialist expertise in the spray drying of APIs and HPAPIs. Founded in 1998, we have a long track record in overcoming complex formulation challenges and then taking products from development batches to Phase II and beyond. From our facility in Switzerland, our 40-strong team deliver both clinical and commercial scale spray drying and capsule filling services, helping pharmaceutical companies across the globe to advance drug development and bring new products to market. Micro-Sphere has specialist expertise in spray drying of aqueous and organic solutions, conventional APIs, HPAPIs, proteins, and capsule filling for dry powder inhalation. Our range of services include: Spray drying (GEA Niro) Spray chilling (GEA Niro) Capsule filling (Harro Höfliger, MG2) Micro-encapsulation Nano-emulsion and liposomes Analytical services for dry powder inhalable (DUSA, NGI, MSLI, ACI) Analytical services for engineered particles (PSD, SEM) Technology transfer Project management Whether your project requirement is at a clinical or commercial scale, our team can help.
Founded Year
1998
Organization Website
micro-sphere.com
Organization Languages
English
Organization Revenue
18000
Current Technologies
apache
openssl
wordpress org
recaptcha
google analytics
google maps
google maps non paid users
mobile friendly
Job Functions
Engineering
Business Development
Operations
lactose for inhalation
nanoemulsions & liposomes
analytical method development & validation
dry powder for inhalation
spraychilling
spraydrying apishpapis organic solvents
stability studies
formulation of apis & hpapis with a particular interest in the field of pulmonary delivery
spray drying of solid dispersions
capsule filling
protein
teratogenic products
spray drying to process amorphous products as well as to isolate apis from organic solvent
microencapsulation
formulation of molecules with poor bioavailability in liposomes & nanoemulsions by the technique of high pressure homogenisation with subsequent spray drying